Discover how personalized medicine and pharmacogenomics testing helped Army Veteran Dariton Robinson manage his high cholesterol with fewer side effects.
VA leads in precision medicine using pharmacogenomics to personalize prescriptions, reducing side effects and improving outcomes for Veterans.
Vietnam Veteran has treatment, community care and clinical trials managed by VA’s Cancer Clinical Research Service
A look at how VA is using genomics to guide smarter screening, treatment and prevention for Veterans, featuring Dr. Jason Vassy.
The findings of this new MVP study underscore the importance and positive impact of diverse representation in genetic research, paving the way for significant advances in health care tailored to Veteran population-specific needs.
The 2024 Innovation Ecosystem fellows will be spending a year advancing initiatives that improve Veteran health care.
The PHASER program offers genetic testing that uses information in a person’s genes to determine how they respond to medicine.
A VA study has found that Pharmacogenomic, or genetic testing, can help providers avoid prescribing antidepressant medications that may have undesirable outcomes.
VA encourages Veterans to talk to their doctors about the signs and symptoms of bladder cancer.
This year’s Veterans Health Administration Innovation Experience (iEx)--on October 22-23--showcased the power of partnerships and innovation.This year’s Veterans Health Administration Innovation Experience (iEx)--on October 22-23--showcased the power of partnerships and innovation.
A physician-investigator at the Washington DC VAMC is a member of the African American Cardiovascular Pharmacogenomics Consortium, created in 2016 to advance precision prescribing—based on patients’ genes—of cardiovascular drugs for African Americans.
Navy Veteran and stage 4 lung cancer survivor, Patrick McGuire will be one of the first participants in a new testing program called PHASeR which will provide free genetic testing to cancer survivors cared for by VA.












